Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas purchased 38,900 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The stock was acquired at an average price of $0.77 per share, with a total value of $29,953.00. Following the purchase, the chief executive officer now directly owns 4,203,689 shares of the company’s stock, valued at approximately $3,236,840.53. The trade was a 0.93 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas purchased 62,500 shares of Cosmos Health stock. The shares were bought at an average cost of $0.80 per share, for a total transaction of $50,000.00.
- On Monday, January 13th, Grigorios Siokas acquired 163,666 shares of Cosmos Health stock. The shares were bought at an average cost of $0.61 per share, with a total value of $99,836.26.
- On Friday, December 20th, Grigorios Siokas bought 257,334 shares of Cosmos Health stock. The shares were bought at an average price of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Stock Performance
Shares of COSM opened at $0.78 on Friday. The firm has a market capitalization of $18.23 million, a P/E ratio of -0.32 and a beta of 5.57. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. Cosmos Health Inc. has a one year low of $0.47 and a one year high of $1.58. The business has a fifty day moving average of $0.73 and a 200 day moving average of $0.90.
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Further Reading
- Five stocks we like better than Cosmos Health
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Bloom Energy: Powering the Future With Decentralized Energy
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What is Insider Trading? What You Can Learn from Insider Trading
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.